Home » Newsletters » BioWorld Asia

BioWorld Asia

June 14, 2000

View Archived Issues

European Biotech Fund Raising Lags, But Products Are Coming

Canada Invests In Virtual Medical Health Institutes

GenOdyssee Gathers $8.6M In Financing For SNP Effort

Taiwan Firm Invests $6.2 Million In Progen For Molecule Development

Peptide Therapeutics Has Positive Results In Phase III Arilvax Trial

Oxford, Aventis Extend Agreement In Cardiovascular Gene Therapy

British Biotech Pares 80 Jobs, With Saved Funds To Push Development

Scotia Gets Boost From Journal Backtracking On Foscan Data

European Industrialists Call For More Backing For Biotech

Transghne Receives $1 Million Milestone from Schering-Plough

ProChon, MorphoSys Form Deal Around Antibody Library

Genset Raises EUR49 Million In Private Placement Of Bonds

ICH Mulls Gene Therapy Rules, Common Application Format

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...